| pubmed-article:18845807 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0286651 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0577631 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0201950 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C1550594 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0428466 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C1548760 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C1547300 | lld:lifeskim |
| pubmed-article:18845807 | lifeskim:mentions | umls-concept:C0580822 | lld:lifeskim |
| pubmed-article:18845807 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:18845807 | pubmed:dateCreated | 2008-11-25 | lld:pubmed |
| pubmed-article:18845807 | pubmed:abstractText | The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial found that treatment with atorvastatin 80 mg per day reduced the risk of stroke and cardiovascular events in patients with a recent transient ischemic attack (TIA) or stroke. We hypothesized this benefit would be greatest in the subgroup of patients with carotid stenosis. | lld:pubmed |
| pubmed-article:18845807 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18845807 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18845807 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18845807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18845807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18845807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18845807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18845807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18845807 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18845807 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18845807 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:SillesenHenri... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:AmarencoPierr... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:GoldsteinLarr... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:MessigMichael... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:HennericiMich... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:ZivinJustinJ | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:WelchK... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:CallahanAlfre... | lld:pubmed |
| pubmed-article:18845807 | pubmed:author | pubmed-author:Stroke... | lld:pubmed |
| pubmed-article:18845807 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18845807 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:18845807 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18845807 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18845807 | pubmed:pagination | 3297-302 | lld:pubmed |
| pubmed-article:18845807 | pubmed:dateRevised | 2009-2-23 | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:meshHeading | pubmed-meshheading:18845807... | lld:pubmed |
| pubmed-article:18845807 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18845807 | pubmed:articleTitle | Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | lld:pubmed |
| pubmed-article:18845807 | pubmed:affiliation | Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Copenhagen O, Denmark. Sillesen@mac.com | lld:pubmed |
| pubmed-article:18845807 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18845807 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18845807 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18845807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18845807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18845807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18845807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18845807 | lld:pubmed |
